[1] AstraZeneca, Med & Payer Evidence Strategy, Resp & Immunol, BioPharmaceut Med, Cambridge, England
[2] AstraZeneca, Med & Payer Evidence Strategy, BioPharmaceut Med Resp, Cambridge, England
[3] AstraZeneca, Med & Payer Evidence Stat, Med Evidence, BioPharmaceut Med, Gothenburg, Sweden
[4] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Hlth Metr Unit, Gothenburg, Sweden
[5] AstraZeneca, Biostat, BioPharmaceut Med, Cambridge, England
[6] AstraZeneca, Real World Data Sci, Med Evidence, BioPharmaceut Med, Cambridge, England
[7] AstraZeneca, Real World Data Sci, Med Evidence, BioPharmaceut Med, Gaithersburg, MD USA
[8] AstraZeneca, Res & Early Dev, Resp & Immunol, BioPharmaceut R&D,Clin, Cambridge, England
[9] Cochin Hosp, Assistance Publ Hop Paris, Dept Resp Med, Paris, France
[10] Univ Paris Cite, Inst Cochin, INSERM, U1016, Paris, France
[11] Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada
[12] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
[13] NOVELTY Study Investigators, Cambridge, England